Feb 14 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 292 mln 254 mln 500 mln
(+15.3 pct) (+51.2 pct) (+70.7 pct)
Operating loss 786 mln loss 633 mln 30 mln
Recurring loss 796 mln loss 668 mln 20 mln
Net
Net loss 748 mln loss 1.56 60 mln
EPS loss 28.51 yen loss 59.89 yen 2.28 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T